PRODE is a Norwegian multicentre study investigating the prognosis of depression in the elderly. The study has included 169 patients who will be followed with assessments after one and three years. The study hypothesis is that elderly patients referred to specialist health service have a poor long term prognosis.
Objective: Depression in the elderly is difficult to treat and is often of chronic or recurrent nature. There is little knowledge about the course and the risk factors for recurrence of depression among elderly people in Norway. The aim of the PRODE-study is to examine the short- and long-term prognosis of elderly depressed patients who are referred for treatment in departments of old age psychiatry. Method: PRODE is a multicentre case-control and longitudinal study of elderly (\>60 years) depressed and non-depressed patients with a one and three year follow-up. Nine participating departments of old age psychiatry used the same standardized instruments to collect data of the patients on depression and other mental health issues, cognition, physical health, medications, functions in activities of daily living, quality of life and family carers' situation. The included patients and controls underwent an MRI scan of the brain according to a comprehensive protocol developed for this project. Furthermore, blood and saliva from the included patients are stored in a Biobank for analyses of pro- and anti-inflammatory cytokines and cortisol. The study included 169 patients (December 2009-January 2013) and will include the same number of non-depressed controls. Outcome Measures (short-term): * Depression as measured with the Montgomery and Asberg Depression Rating Scale (MADRS), Cornell Scale for Depression in Dementia (CSDD) and Hospital Anxiety and Depression Scale (HADS), trajectories and clinical assessments. * Function in activities of daily living Outcome measures (long-term): * Cognition as measured by Mini Mental State Examination (MMSE) and diagnosis of dementia. * Depression, recurrence of depression and as measured wtih the MADRS and CSDD. * Use of health care facilities; nursing home. * Mortality * Function in activities of daily living
Study Type
OBSERVATIONAL
Enrollment
169
Innlandet Hospital Trust
Ottestad, Norway
Depression
Response (50% improvement on the Montgomery and Asberg Depression Rating Scale (MADRS) score) Remission (defined as score of 9 or less on the MADRS) The MADRS is a measurement of the severity of depression and consists of 10 items rated from 0 points (no symptoms) to 6 (severe symptoms)
Time frame: Patients were follow during their stay in the hospital; average days of stay in hospital = 68.3 (SD=46.8)
Depression
Relapse/recurrence of depression
Time frame: 1 year after inclusion to the study
Number of Patients With a Diagnosis of Dementia
One year after inclusion to the study, there will be a clinical assessment of the patient including a MMSE, if possible, and to evaluate if the patients have dementia.
Time frame: 1 year after inclusion to the study
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.